Featured Articles
-
Can A Shared Biomanufacturing Facility Be The Answer To The Demand Forecasting Dilemma?
8/13/2018
Using a shared biomanufacturing facility, a biomanufacturer can minimize its investment while mitigating the risks of demand uncertainty and maximizing time to market.
-
The Transparent CDMO: Maintain Autonomy In Biomanufacturing Partnership
7/6/2018
Complete transparency and open communication are both critical for a successful partnership. What business practices should you look for to ensure your CDMO can offer this type of commitment?
-
Pulse Check: How To Assess Your In-House Biomanufacturing Capabilities
6/18/2018
By checking the pulse of your organization, you can identify gaps and develop a plan for how to address them, so you can make the right decisions at the right time.
-
Modular Approaches For Diverse Molecules: Reinventing Smart Bioprocessing
2/23/2018
Smart bioprocessing uses bioinformatics, lab-scale processing, and analytics to create efficient and cost-effective production processes that can be verified at lab-scale before scale-up.
-
Protein Analysis With Size Exclusion Chromatography (SEC)
2/20/2018
This white paper presents fundamentals about analytical SEC and describes how our new-generation agarose-based SEC columns are used in analysis of biomolecules.
-
Buffer Management Solutions For Large-Scale Biomanufacturing
2/1/2018
How outsourcing and technologies such as in-line conditioning and in-line dilution can help prevent resource constraints, save time, and reduce manufacturing footprint and cost in buffer preparation.
-
Expand Capacity In Buffer Management
2/1/2018
Biomanufacturing requires large volumes of buffers, and preparation of these liquids can quickly become a bottleneck. Here, two options that can help intensify your large-scale buffer management are presented.
-
Roivant Accelerates Process Development To Speed Orphan Therapy To Market
11/10/2017
This case study shares the work of Cytiva’s Fast Trak Services team to help accelerate development of a process for cGMP production of material for toxicology studies.
-
Collaborative Project To Accelerate Downstream Biosimilar Processes
6/11/2017
This case study demonstrates the optimization of the downstream purification process to improve product purity and recovery of the biosimilar Fc-fusion protein.
-
How Biogen Integrated PAT With End-To-End Supply Chain Transparency
To drive dependable critical process control requirements, Biogen explored novel strategies to increase process and raw material control and optimize communication of data throughout the supply chain.